Psychiatry & Neurology Doctors in Dartmouth, MA Accepting Medicare

6 Psychiatry & Neurology doctors found. Showing 1 - 6

Audrey Lorraine Harrell, Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 531 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991

Dr. Robert Wade Conroy, D.O. Psychiatry & Neurology - Sleep Medicine Medicare: Accepting Medicare Assignments Practice Location: 535 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991

Arun Rajan, M.D. Psychiatry & Neurology - Sleep Medicine Medicare: Accepting Medicare Assignments Practice Location: 237a State Rd, Dartmouth, MA 02747 Phone: 508-993-9760    Fax: 508-993-9764

Dr. Juan E Cuebas, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 535 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991

John Stamoulis, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 535 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991

Lucyna Zofia Czarnota-dolliver, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 531 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991

News Archive

Scientists identify marker that subdivides insulin-producing beta cells of the pancreas

The marker Flattop subdivides the insulin-producing beta cells of the pancreas into those that maintain glucose metabolism and into immature cells that divide more frequently and adapt to metabolic changes.

PD-L1 inhibition well-tolerated, active in metastatic RCC

The programmed death-ligand 1 inhibitor atezolizumab has a favourable toxicity profile and shows anti-tumour activity in previously treated patients with metastatic renal cell carcinoma, according to phase Ia trial findings.

World shortage of molybdenum may hinder nuclear medicine services

Problems with the world production and supply of molybdenum are leading to shortages of radioisotopes for nuclear medicine imaging tests, according to an editorial in the journal Nuclear Medicine Communications, official journal of the British Nuclear Medicine Society (BNMS).

Study offers potential new strategy for use of retinoids against some breast cancers

Estrogen-positive breast cancers are often treated with anti-estrogen therapies. But about half of these cancers contain a subpopulation of cells marked by the protein cytokeratin 5 (CK5), which resists treatment - and breast cancers with higher CK5 expression have poorer prognosis.

Read more Medical News

› Verified 5 days ago